Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401 (Q83305244)
Jump to navigation
Jump to search
scientific article published on 08 May 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401 |
scientific article published on 08 May 2006 |
Statements
Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401 (English)
Per Malmström
Scandinavian Breast Group Trial 9401
Minna Tanner
Jorma Isola
Björn Erikstein
Pirkko Kellokumpu-Lehtinen
Nils Wilking
Jonas Nilsson